Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2312]

Assessing biosimilars in the real world setting

Niels Boone - Zuyderland Medical Center, Heerlen, Netherlands

Assessing biosimilars in the real world setting ( Niels Boone - Zuyderland Medical Center, Heerlen, Netherlands )

Comment: Supporting a sustainable biosimilar solution

Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands

Comment: Supporting a sustainable biosimilar solution ( Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands )

Comment: Use of biosimilar monoclonal antibodies in the clinic

Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands

Comment: Use of biosimilar monoclonal antibodies in the clinic ( Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands )

Comment: Critical quality attributes of biosimilars

Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands

Comment: Critical quality attributes of biosimilars ( Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands )

Comment: Immunogenicity of biosimilars

Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands

Comment: Immunogenicity of biosimilars ( Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands )

Highlights from ESMO 2019

Prof Josep Tabernero - ESMO President

Highlights from ESMO 2019 ( Prof Josep Tabernero - ESMO President )

Holistic management of patients with ALK-positive NSCLC

Rachel Thomas and Jackie Fenemore

Holistic management of patients with ALK-positive NSCLC ( Rachel Thomas and Jackie Fenemore )

Role of molecular diagnostics in prostate cancer

Dr Elena Castro and Dr Shahneen Sandhu

Role of molecular diagnostics in prostate cancer ( Dr Elena Castro and Dr Shahneen Sandhu )

Real-world use of carfilzomib in relapsed multiple myeloma patients with pre...

Dr Jo Caers - Centre Hospitalier Universitaire de Liège, Liège, Belgium

Real-world use of carfilzomib in relapsed multiple myeloma patients with pre-existing cardiovascular comorbidities ( Dr Jo Caers - Centre Hospitalier Universitaire de Liège, Liège, Belgium )

Successful implementation of biosimilars through effective communication

Dr Pauline Leonard - The Whittington Hospital, London, UK

Successful implementation of biosimilars through effective communication ( Dr Pauline Leonard - The Whittington Hospital, London, UK )

Practical considerations for introducing biosimilars

Simon Cheesman - University College Hospital, London, UK

Practical considerations for introducing biosimilars ( Simon Cheesman - University College Hospital, London, UK )

How real-world data generation can assist biosimilar implementation

Simon Cheesman - University College Hospital, London, UK

How real-world data generation can assist biosimilar implementation ( Simon Cheesman - University College Hospital, London, UK )

More from ecancer